BioInvestors Network
Investors meet BioEntrepreneurs
BioAngels is an exclusive matchmaking concept for private investors such as business angels, wealthy individuals, family offices and conventional venture capital investors interested in life sciences & health technology investments.
Matchmaking
We introduce private investors to selected, innovative start-up projects at an early stage.
BioEntrepreneurs planning a spin-off or start-up in search of investors can apply with us to present their business idea to our BioAngels. The presenting teams will be prepared by us to submit all relevant information needed for deciding on an investment in the life sciences sector in an appropriate manner.
„On the BioAngels Pitch Day, it is easy to talk to the teams. That would be harder on large investment conferences. I also greatly appreciate the exchange with the other investors.“
Focus on health care sector
Our circle of investors is interested in participating in the following areas:
- Innovative drug development
- New diagnosis procedures
- Big data & digital health
- New drug technologies and approaches to regenerative drugs
- Innovative platform technologies and services
„The preparation by the team of BioM was very good and intensive. The criticizing feedback has helped us tailor our presentation to the demands of investors.“
More on the topic
21.07.2026
BioM, bioRN and ESMT Berlin join forces to create a Unified Hub for healthcare innovation in Germany
BioM Biotech Cluster Development GmbH, bioRN Life Science Cluster and ESMT Berlin announced the establishment of a Unified Hub for Healthcare Innovation. Through this alliance, the two…
21.07.2026
TigerShark Science celebrates a double success: the Bavarian Start-up Award and victory in the Northern Bavaria Business Plan Competition.
A major success for the Würzburg-based biotech start-up TigerShark Science: the company has been awarded the 2026 Bavarian Start-up Prize in the ‘Start-up’ category. The team also secured…
17.07.2026
Munich start-up and m4 Award winner BugSense receives EXIST funding for rapid UTI diagnostics
Munich-based start-up BugSense Diagnostics has secured EUR 1.23 million through the EXIST Research Transfer funding programme of the German Federal Ministry for Economic Affairs and Energy…